They showed that the overexpression of a wild-type or Thr286 phosphomimic form of CaMKII increased proliferation rates of neuroblastoma and breast cancer cells, whereas overexpression of a Thr253 phosphomimic form significantly reduced proliferation rates in these cells. The gene discussed is CAMK2G; the disease is breast carcinoma.